Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...

HDFC Mid-Cap Opportunities Fund (G) 1266.32 78,69,749 1.62 HDFC Mid-Cap Opportunities Fund (IDCW) 1266.32 78,69,749 1.62 HDFC Mid-Cap Opportunities Fund - Direct (IDCW) 1266.32 78,69,749 1.62 HDFC Mid ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The FDA's expanded approval will allow the drug to be more accessible with insurance. Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients ...

Glenmark Pharmaceuticals Ltd share price was up by 3.89% from the previous closing price of ₹1,399.20. Who are peers of Glenmark Pharmaceuticals Ltd? The peers of Glenmark Pharmaceuticals Ltd ...

11 Jun, 2007 10 Sep, 2007 2 1 For every share held, the holder will receive 2 shares post the split adjustment. 31 Jul, 2003 23 Oct, 2003 10 2 For every share held, the holder will receive 5 ...

Nasal decongestant spray can help relieve sinus infection symptoms in the short term. But you should limit your use to no more than 3 days to avoid a rebound effect, which can lead to worsening ...

Alivus Life Sciences Ltd share price was up by 2.85% from the previous closing price of ₹1,167.00. Who are peers of Alivus Life Sciences Ltd? The peers of Alivus Life Sciences Ltd are Sun ...